Reza Ghiladi


Biological/medicinal inorganic chemistry. Research is focused primarily on i) the elucidation of enzyme structure-function-spectroscopy relationships as they relate to disease states, primarily the activation of the anti-tubercular drug isoniazid by the hemoprotein KatG; ii) metalloprotein (re)engineering via incorporation of unnatural amino acids into enzyme active sites; and iii) design and synthesis of novel anti-tubercular PDT agents.